News
A common anti-nausea drug used during chemotherapy may do more than ease discomfort, it could help women with aggressive ...
Recent health headlines include FDA's eye safety concerns over GSK's cancer drug, escalating malnutrition rates in Gaza ...
The FDA approved four drugs last year without any U.S. trial participants, but has maintained a tougher stance on China, even ...
This summary highlights significant events in the health sector, including Johnson & Johnson's profit boost from Darzalex, safety concerns for GSK's cancer drug, refugee malnutrition in Gaza, KKR's ...
A PDAC cell line was generated from a patient who consented to make the genetic code of her cancer cells publicly available ...
Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the ...
A PDAC cell line was generated from a patient who consented to make the genetic code of her cancer cells publicly available ...
The FDA clears GL-IL2-138, a groundbreaking oral drug modulating natural IL-2, set to revolutionize treatment in oncology.
They want to gain a deeper understanding of why the disease behaves differently in these patients. Read more at ...
Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...
China's domestic biotech industry is entering a new phase of international influence, as homegrown innovative drugs ...
A groundbreaking drug, blinatumomab, is transforming leukemia treatment, offering new hope for patients like 4-year-old Madi Seivert.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results